NCT00004313View on ClinicalTrials.gov

Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone Replacement for Primary Adrenal Insufficiency

PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 31, 1995

Conditions
Addison's Disease
Interventions
DRUG

dehydroepiandrosterone

All Listed Sponsors
collaborator

University of California, Los Angeles

OTHER

lead

National Center for Research Resources (NCRR)

NIH

NCT00004313 - Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone Replacement for Primary Adrenal Insufficiency | Biotech Hunter | Biotech Hunter